Features Archives - BaseLaunch

Scientist in a Lab Coat looking at Laboratory samples

All Features

News bulletin: CSL Behring becomes BaseLaunch partner for Phase II

We are very pleased to welcome CSL Behring, one of the largest biotech companies in the world, as a partner in BaseLaunch Phase II. Read the…

clement30.07.2020

All Features

Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner

Special Report: The latest addition to the partner portfolio all the way from Asia Pacific. A warm welcome to Bridge Biotherapeutics, for which CEO, James Lee,…

clement14.07.2020

All Features

News flash: Roivant Sciences continues partnership

We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at…

clement24.06.2020

All Features

Roche becomes a founding partner of BaseLaunch Phase II

We are proud to announce that Roche has become a founding partner in the next phase of BaseLaunch. With this commitment, Roche renews its partnership…

clement15.05.2020

All Features

Research Study Opportunity

There is an opportunity to participate in a research study interview taking place for those with knowledge of the biopharmaceutical industry in Switzerland. The research should…

clement11.05.2020

All Features

Looking for people for exciting projects

We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing…

clement11.05.2020

All Features

KPMG: COVID-19 feature- Build resilience

From our partner, KPMG: Proving an online knowledge base for the COVID-19 times. KPMG has put together an online resource page for these challenging and…

clement08.05.2020

Features

CHF 15M in Series A Financing, raised by ImmunOs

ImmunOs Therapeutics AG is a Swiss biotechnology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer. They have recently…

clement17.12.2019

Features

15 companies chosen for Phase 1

The selection committee has chosen 15 promising projects for Phase I. The projects all focus on developing innovative technologies to dramatically change patient outcomes in a variety…

clement03.10.2019

Features

Looking for biopharma professionals with experience in areas such as R&D/commercial/BD&L to support emerging biotech companies

Starting a biotech and developing drugs needs world class science as a foundation. But equally important is to back up the (usually) academic inventors of…

clement23.09.2019

Features

News bulletin: CSL Behring becomes BaseLaunch partner for Phase II

Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner

News flash: Roivant Sciences continues partnership

Roche becomes a founding partner of BaseLaunch Phase II

Research Study Opportunity

Looking for people for exciting projects

KPMG: COVID-19 feature- Build resilience

CHF 15M in Series A Financing, raised by ImmunOs

15 companies chosen for Phase 1

Looking for biopharma professionals with experience in areas such as R&D/commercial/BD&L to support emerging biotech companies

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us